COST-UTILITY ANALYSIS OF UPFRONT PHARMACOTHERAPY COMPARED TO AN UPFRONT SURGICAL INTERVENTION FOR PATIENTS WITH BENIGN PROSTATE HYPERPLASIA

被引：0
|
作者：
Elterman, Dean [1 ]
Masucci, Lisa [2 ]
Shepherd, Shaun [3 ]
Erman, Aysegeul [2 ]
Krahn, Murray [4 ]
机构：
[1] Univ Hlth Network, Toronto Western Hosp, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] McMaster Univ, Toronto, ON, Canada
[4] Univ Hlth Network, Toronto, ON, Canada
来源：
NEUROUROLOGY AND URODYNAMICS | 2018年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
M31
引用
收藏
页码：S594 / S595
页数：2
相关论文
共 50 条
  • [1] COST-UTILITY ANALYSIS OF UPFRONT PHARMACOTHERAPY COMPARED TO AN UPFRONT SURGICAL INTERVENTION FOR PATIENTS WITH BENIGN PROSTATE HYPERPLASIA
    Elterman, Dean
    Erman, Aysegul
    Masucci, Lisa
    Shepherd, Shaun
    Krahn, Murray
    JOURNAL OF UROLOGY, 2018, 199 (04): : E33 - E33
  • [2] Cost-utility analysis of imrecoxib compared with celecoxib for patients with osteoarthritis
    Sun, Xueshan
    Zhen, Xuemei
    Hu, Xiaoqian
    Li, Yuanyuan
    Gu, Shuyan
    Gu, Yuxuan
    Zhao, Zixuan
    Yang, Wei
    Dong, Hengjin
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (07)
  • [3] Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis
    Sun, Xueshan
    Zhen, Xuemei
    Hu, Xiaoqian
    Li, Yuanyuan
    Gu, ShuYan
    Gu, Yuxuan
    Zhao, Zixuan
    Yang, Wei
    Dong, Hengjin
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2021, 19 (01)
  • [4] Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis
    Xueshan Sun
    Xuemei Zhen
    Xiaoqian Hu
    Yuanyuan Li
    ShuYan Gu
    Yuxuan Gu
    Zixuan Zhao
    Wei Yang
    Hengjin Dong
    Cost Effectiveness and Resource Allocation, 19
  • [5] 1-year cost-utility analysis of prostate artery embolization (PAE) versus transurethral resection of the prostate (TURP) in benign prostatic hyperplasia (BPH)
    Patel, Nikisha
    Yung, Nathan
    Vigneswaran, Ganesh
    de Preux, Laure
    Maclean, Drew
    Harris, Mark
    Somani, Bhaskar
    Bryant, Timothy
    Hacking, Nigel
    Modi, Sachin
    BMJ SURGERY INTERVENTIONS & HEALTH TECHNOLOGIES, 2021, 3 (01)
  • [6] A COST-UTILITY ANALYSIS OF IDET COMPARED WITH SPINAL FUSION
    Stamuli, E.
    Claxton, K.
    Grevitt, M. P.
    Hegarty, J.
    Righetti, C.
    VALUE IN HEALTH, 2009, 12 (07) : A381 - A381
  • [7] Cost analysis of Greenlight photoselective vaporization of the prostate compared to transurethral resection of the prostate for benign prostatic hyperplasia
    Masucci, Lisa
    Erman, Aysegul
    Krahn, Murray D.
    Elterman, Dean
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2018, 12 (12): : 382 - 387
  • [8] Cost-utility of minimally invasive therapies vs. pharmacotherapy as initial therapy for benign prostatic hyperplasia A Canadian healthcare payer perspective
    Sahakyan, Yeva
    Erman, Aysegul
    Bhojani, Naeem
    Chughtai, Bilal
    Zorn, Kevin C.
    Sander, Beate
    Elterman, Dean S.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2023, 17 (04): : 103 - 110
  • [9] Cost-Utility Analysis of Obesity Therapy: A Comparison of Lifestyle Intervention to Surgical, and Endoscopic Strategies
    Chiang, Austin L.
    Tapper, Elliot B.
    Thompson, Christopher C.
    GASTROENTEROLOGY, 2016, 150 (04) : S86 - S86
  • [10] Interpreting cost-utility analysis of prostate cancer treatment
    James B. Yu
    Nature Reviews Urology, 2013, 10 : 129 - 131
12345